REFERENCES
1. Toraih EA, Elshazli RM, Hussein MH, Elgaml A, Amin MN, El-Mowafy M,
El-Mesery M, Ellythy A, Duchesne J, Killackey MT et al. 2020.
Association of cardiac biomarkers and comorbidities with increased
mortality, severity, and cardiac injury in covid-19 patients: A
meta-regression and decision tree analysis. J Med Virol.
2. Covid C, COVID C, COVID C, Bialek S, Gierke R, Hughes M, McNamara LA,
Pilishvili T, Skoff T. 2020. Coronavirus disease 2019 in
children—united states, february 12–april 2, 2020. Morbidity and
Mortality Weekly Report. 69(14):422.
3. Docherty AB, Harrison EM, Green CA, Hardwick HE, Pius R, Norman L,
Holden KA, Read JM, Dondelinger F, Carson G. 2020. Features of 16,749
hospitalised uk patients with covid-19 using the isaric who clinical
characterisation protocol. medRxiv.
4. Viner RM, Whittaker E. 2020. Kawasaki-like disease: Emerging
complication during the covid-19 pandemic. Lancet. 395(10239):1741-1743.
5. Bi Q, Wu Y, Mei S, Ye C, Zou X, Zhang Z, Liu X, Wei L, Truelove SA,
Zhang T. 2020. Epidemiology and transmission of covid-19 in 391 cases
and 1286 of their close contacts in shenzhen, china: A retrospective
cohort study. The Lancet Infectious Diseases.
6. Zhang J, Litvinova M, Liang Y, Wang Y, Wang W, Zhao S, Wu Q, Merler
S, Viboud C, Vespignani A et al. 2020. Changes in contact patterns shape
the dynamics of the covid-19 outbreak in china. Science.
368(6498):1481-1486.
7. Cheung EW, Zachariah P, Gorelik M, Boneparth A, Kernie SG, Orange JS,
Milner JD. 2020. Multisystem inflammatory syndrome related to covid-19
in previously healthy children and adolescents in new york city. JAMA.
8. Chiu JS, Lahoud-Rahme M, Schaffer D, Cohen A, Samuels-Kalow M. 2020.
Kawasaki disease features and myocarditis in a patient with covid-19.
Pediatr Cardiol.1-3.
9. Rowley AH, Shulman ST. 2010. Pathogenesis and management of kawasaki
disease. Expert Rev Anti Infect Ther. 8(2):197-203.
10. Holman RC, Belay ED, Christensen KY, Folkema AM, Steiner CA,
Schonberger LB. 2010. Hospitalizations for kawasaki syndrome among
children in the united states, 1997-2007. Pediatric Infectious Disease
Journal. 29(6):483-488.
11. Esper F, Shapiro ED, Weibel C, Ferguson D, Landry ML, Kahn JS. 2005.
Association between a novel human coronavirus and kawasaki disease. J
Infect Dis. 191(4):499-502.
12. Shirato K, Imada Y, Kawase M, Nakagaki K, Matsuyama S, Taguchi F.
2014. Possible involvement of infection with human coronavirus 229e, but
not nl63, in kawasaki disease. J Med Virol. 86(12):2146-2153.
13. Verdoni L, Mazza A, Gervasoni A, Martelli L, Ruggeri M, Ciuffreda M,
Bonanomi E, D’Antiga L. 2020. An outbreak of severe kawasaki-like
disease at the italian epicentre of the sars-cov-2 epidemic: An
observational cohort study. Lancet. 395(10239):1771-1778.
14. Feldstein LR, Rose EB, Horwitz SM, Collins JP, Newhams MM, Son MBF,
Newburger JW, Kleinman LC, Heidemann SM, Martin AA et al. 2020.
Multisystem inflammatory syndrome in u.S. Children and adolescents. N
Engl J Med.
15. Pilania RK, Jindal AK, Srikrishna VV, Samprathi M, Singhal M, Singh
S. 2019. Hypotension in a febrile child-beware of kawasaki disease shock
syndrome. J Clin Rheumatol.
16. Riphagen S, Gomez X, Gonzalez-Martinez C, Wilkinson N, Theocharis P.
2020. Hyperinflammatory shock in children during covid-19 pandemic.
Lancet. 395(10237):1607-1608.
17. McInnes MDF, Moher D, Thombs BD, McGrath TA, Bossuyt PM, Group
atP-D. 2018. Preferred reporting items for a systematic review and
meta-analysis of diagnostic test accuracy studies: The prisma-dta
statement. JAMA. 319(4):388-396.
18. Behmadi M, Alizadeh B, Malek A. 2019. Comparison of clinical
symptoms and cardiac lesions in children with typical and atypical
kawasaki disease. Med Sci (Basel). 7(4).
19. Wallace BC, Dahabreh IJ, Trikalinos TA, Lau J, Trow P, Schmid CH.
2012. Closing the gap between methodologists and end-users: R as a
computational back-end. 2012. 49(5):15.
20. Pierce CA. 2008. Software review: Borenstein, m., hedges, l. V.,
higgins, j. P. T., & rothstein, h. R. (2006). Comprehensive
meta-analysis (version 2.2.027) [computer software]. Englewood, nj:
Biostat. Organizational Research Methods. 11(1):188-191.
21. DerSimonian R, Laird N. 1986. Meta-analysis in clinical trials.
Control Clin Trials. 7(3):177-188.
22. Andreano A, Rebora P, Valsecchi MG. 2015. Measures of single arm
outcome in meta-analyses of rare events in the presence of competing
risks. Biometrical Journal. 57(4):649-660.
23. Lin L, Chu H. 2018. Quantifying publication bias in meta-analysis.
Biometrics. 74(3):785-794.
24. Xia W, Shao J, Guo Y, Peng X, Li Z, Hu D. 2020. Clinical and ct
features in pediatric patients with covid-19 infection: Different points
from adults. Pediatr Pulmonol. 55(5):1169-1174.
25. Capone CA, Subramony A, Sweberg T, Schneider J, Shah S, Rubin L,
Schleien C, Northwell Health C-RC, Epstein S, Johnson JC et al. 2020.
Characteristics, cardiac involvement, and outcomes of multisystem
inflammatory disease of childhood (mis-c) associated with sars-cov-2
infection. J Pediatr.
26. Park YW, Han JW, Park IS, Kim CH, Yun YS, Cha SH, Ma JS, Lee SB, Kim
CH, Lee HJ et al. 2005. Epidemiologic picture of kawasaki disease in
korea, 2000-2002. Pediatr Int. 47(4):382-387.
27. Song D, Yeo Y, Ha K, Jang G, Lee J, Lee K, Son C, Lee J. 2009. Risk
factors for kawasaki disease-associated coronary abnormalities differ
depending on age. Eur J Pediatr. 168(11):1315-1321.
28. de La Harpe M, di Bernardo S, Hofer M, Sekarski N. 2019. Thirty
years of kawasaki disease: A single-center study at the university
hospital of lausanne. Frontiers in Pediatrics. 7(11).
29. Yan F, Pan B, Sun H, Tian J, Li M. 2019. Risk factors of coronary
artery abnormality in children with kawasaki disease: A systematic
review and meta-analysis. Frontiers in pediatrics. 7:374-374.
30. Shulman ST, Rowley AH. 2015. Kawasaki disease: Insights into
pathogenesis and approaches to treatment. Nat Rev Rheumatol.
11(8):475-482.
31. Zhou F, Yu T, Du R, Fan G, Liu Y, Liu Z, Xiang J, Wang Y, Song B, Gu
X et al. 2020. Clinical course and risk factors for mortality of adult
inpatients with covid-19 in wuhan, china: A retrospective cohort study.
Lancet. 395(10229):1054-1062.
32. McGonagle D, Sharif K, O’Regan A, Bridgewood C. 2020. The role of
cytokines including interleukin-6 in covid-19 induced pneumonia and
macrophage activation syndrome-like disease. Autoimmunity Reviews.
19(6):102537.
33. De Benedetti F, Brunner HI, Ruperto N, Kenwright A, Wright S, Calvo
I, Cuttica R, Ravelli A, Schneider R, Woo P et al. 2012. Randomized
trial of tocilizumab in systemic juvenile idiopathic arthritis. New
England Journal of Medicine. 367(25):2385-2395.
34. Forster P, Forster L, Renfrew C, Forster M. 2020. Phylogenetic
network analysis of sars-cov-2 genomes. Proceedings of the National
Academy of Sciences. 117(17):9241.
35. Riphagen S, Gomez X, Gonzalez-Martinez C, Wilkinson N, Theocharis P.
2020. Hyperinflammatory shock in children during covid-19 pandemic.
Lancet. 395(10237):1607-1608.
36. Verdoni L, Mazza A, Gervasoni A, Martelli L, Ruggeri M, Ciuffreda M,
Bonanomi E, D’Antiga L. 2020. An outbreak of severe kawasaki-like
disease at the italian epicentre of the sars-cov-2 epidemic: An
observational cohort study. Lancet.
37. Chiotos K, Bassiri H, Behrens EM, Blatz AM, Chang J, Diorio C,
Fitzgerald JC, Topjian A, John ARO. 2020. Multisystem inflammatory
syndrome in children during the covid-19 pandemic: A case series. J
Pediatric Infect Dis Soc.
38. Grimaud M, Starck J, Levy M, Marais C, Chareyre J, Khraiche D,
Leruez-Ville M, Quartier P, Leger PL, Geslain G et al. 2020. Acute
myocarditis and multisystem inflammatory emerging disease following
sars-cov-2 infection in critically ill children. Ann Intensive Care.
10(1):69.
39. Toubiana J, Poirault C, Corsia A, Bajolle F, Fourgeaud J, Angoulvant
F, Debray A, Basmaci R, Salvador E, Biscardi S et al. 2020.
Kawasaki-like multisystem inflammatory syndrome in children during the
covid-19 pandemic in paris, france: Prospective observational study.
BMJ. 369:m2094.
40. Miller J, Cantor A, Zachariah P, Ahn D, Martinez M, Margolis K.
2020. Gastrointestinal symptoms as a major presentation component of a
novel multisystem inflammatory syndrome in children (mis-c) that is
related to covid-19: A single center experience of 44 cases.
Gastroenterology.
41. Perez-Toledo M, Faustini SE, Jossi SE, Shields AM, Kanthimathinathan
HK, Allen JD, Watanabe Y, Goodall M, Wraith DC, Veenith TV et al. 2020.
Serology confirms sars-cov-2 infection in pcr-negative children
presenting with paediatric inflammatory multi-system syndrome. medRxiv.
42. Whittaker E, Bamford A, Kenny J, Kaforou M, Jones CE, Shah P,
Ramnarayan P, Fraisse A, Miller O, Davies P et al. 2020. Clinical
characteristics of 58 children with a pediatric inflammatory multisystem
syndrome temporally associated with sars-cov-2. JAMA.
43. Blondiaux E, Parisot P, Redheuil A, Tzaroukian L, Levy Y, Sileo C,
Schnuriger A, Lorrot M, Guedj R, Ducou le Pointe H. 2020. Cardiac mri of
children with multisystem inflammatory syndrome (mis-c) associated with
covid-19: Case series. Radiology.202288.
44. Pouletty M, Borocco C, Ouldali N, Caseris M, Basmaci R, Lachaume N,
Bensaid P, Pichard S, Kouider H, Morelle G et al. 2020. Paediatric
multisystem inflammatory syndrome temporally associated with sars-cov-2
mimicking kawasaki disease (kawa-covid-19): A multicentre cohort. Ann
Rheum Dis.
45. Ramcharan T, Nolan O, Lai CY, Prabhu N, Krishnamurthy R, Richter AG,
Jyothish D, Kanthimathinathan HK, Welch SB, Hackett S et al. 2020.
Paediatric inflammatory multisystem syndrome: Temporally associated with
sars-cov-2 (pims-ts): Cardiac features, management and short-term
outcomes at a uk tertiary paediatric hospital. Pediatr Cardiol.1-11.
46. Kaushik S, Aydin SI, Derespina KR, Bansal PB, Kowalsky S, Trachtman
R, Gillen JK, Perez MM, Soshnick SH, Conway EE, Jr. et al. 2020.
Multisystem inflammatory syndrome in children (mis-c) associated with
sars-cov-2 infection: A multi-institutional study from new york city. J
Pediatr.
47. sermet i, temmam s, huon c, behillil s, gadjos v, bigot t, lurier t,
chretien d, backovick m, Moisan-Delaunay A et al. 2020. Prior infection
by seasonal coronaviruses does not prevent sars-cov-2 infection and
associated multisystem inflammatory syndrome in children.
medRxiv.2020.2006.2029.20142596.